Federation Des Caisses Desjardins Du Quebec Galera Therapeutics, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

  • $18.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Aug 14, 2024
SELL
$0.09 - $0.27 $4,500 - $13,500
-50,000 Closed
0 $0
Q3 2023

Aug 14, 2024
BUY
$0.17 - $3.0 $8,500 - $150,000
50,000 New
50,000 $8.75 Million
Q2 2023

Aug 14, 2024
SELL
$2.5 - $3.42 $5,250 - $7,182
-2,100 Closed
0 $0
Q1 2022

Aug 14, 2024
BUY
$2.01 - $4.19 $4,221 - $8,799
2,100 New
2,100 $5 Million
Q4 2021

Aug 30, 2024
BUY
$1.27 - $8.28 $2,667 - $17,388
2,100 New
2,100 $9.64 Million

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.34M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email